Cardio Diagnostics Holdings, Inc. (CDIO)

1.87 -0.08 (-4.10%) USD  |  NASDAQ  |  Sep 28, 16:00
1.87 0.00 (0.00%) After-Hours: 17:04
More

Cardio Diagnostics Holdings Research and Development Expense (TTM) : 0.7686M for June 30, 2026

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for CDIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Research and Development Expense (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 0.7686M
March 31, 2026 0.613M
December 31, 2025 0.4854M
September 30, 2025 0.2043M
June 30, 2025 0.0205M
March 31, 2025 0.0205M
Date Value
December 31, 2024 0.0291M
September 30, 2024 0.0309M
June 30, 2024 0.0643M
March 31, 2024 0.0694M
December 31, 2023 0.1452M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 45.26M
Exicure, Inc. 2.029M
Century Therapeutics, Inc. 66.62M
Absci Corp. 86.49M
Celularity, Inc. 9.222M